All Q2 FY26 results →
V.

Ventas, Inc.

Q2 FY26Health Care REITs

Ventas, Inc. Q2 FY26 Results — Earnings Call Analysis

Q2 FY26 earnings call: what management said on revenue, margins and capex.

Price₹86
Market cap₹41.7K Cr
P/E160.7
Updated29 May 2026
Read4 min read

What the Q2 FY26 call signalled

1 of 2 strong

RevenueModerate growth
CapexCapex planned

The short version

- Ventas expects continued strong growth in senior housing, with SHOP same-store NOI growth projected at 16% midpoint for 2026, up from 15%. - Ventas expects normalized FFO per share in 2026 to range from $3.83 to $3.89, with a midpoint of $3.86, reflecting a $0.03 increase from prior guidance.

From Ventas, Inc.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.

Revenue & Sales Performance

Moderate growth
  • Ventas expects continued strong growth in senior housing, with SHOP same-store NOI growth projected at 16% midpoint for 2026, up from 15%.
  • U.S. occupancy increased 370 basis points; still below peak, indicating room for volume growth.
  • Revenue growth expected around 8.75%, driven by both occupancy and rate increases.
  • Incremental margin for occupancy growth remains around 50%, with some communities delivering up to 70% at stable high occupancy.
  • External investments, including $3 billion targeted in senior housing acquisitions in 2026, support growth.
  • Revel portfolio (luxury independent living) has mid-70% occupancy, with significant upside expected through management improvements and Ventas OI initiatives.
  • Operators are leveraging increased demand to raise community fees and entrance fees, contributing to revenue growth.

2 more points from Ventas, Inc.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Ventas, Inc. said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Majority of investments in senior housing, particularly SHOP portfolio, with $6+ billion added in investments.
  • Revel portfolio requires additional investment to be competitive; majority of CapEx expected to be completed by next month.
  • Focus on accretive growth investments delivering unlevered IRRs in the low- to mid-teens.
  • Executing organically and externally to grow SHOP with strong capital deployment.
  • Strategic investments include off-market and bilateral deals, leveraging Ventas OI platform.
  • Capital invested in property improvements and platform scaling, including investments in people, process, and technology to accelerate growth.

2 more points from Ventas, Inc.'s call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Ventas, Inc. said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Ventas updated their investment guidance from $2.5 billion to $3 billion for 2026.
  • The pipeline is larger with consistent win rates despite increased competition.
  • Approximately $3 billion in pipeline value-add opportunities, some delivering mid-teen unlevered IRRs.
  • Over 60% of their acquisitions are off-market; about 44 operators involved.
  • $2.4 billion of equity raised for 2026 investment activity, including $800 million settled in Q1 and $1.6 billion from forward equity sales agreements.
  • Investment momentum is strong, with confidence in executing transactions at attractive cap rates (high 6% range expected).

2 more points from Ventas, Inc.'s call on order book

Create a free account to keep reading this call

Others in Health Care REITs this season

  • Healthpeak Properties, Inc. (Q2 FY26)

    Healthpeak Properties, Inc. Q2 FY26 quarterly results analysis. **Life Science Occupancy Growth:** Expect total life science occupancy to increase by at least 1

  • Omega Healthcare Investors, Inc. (Q2 FY26)

    Omega Healthcare Investors, Inc. Q2 FY26 quarterly results analysis. Skilled nursing facilities (SNFs) expected to grow at a high single-digit to low double-dig

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Ventas, Inc. and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Ventas, Inc. Q2 FY26 results?

- Ventas expects continued strong growth in senior housing, with SHOP same-store NOI growth projected at 16% midpoint for 2026, up from 15%. - Ventas expects normalized FFO per share in 2026 to range from $3.83 to $3.89, with a midpoint of $3.86, reflecting a $0.03 increase from prior guidance.

What is Ventas, Inc. share price analysis?

Ventas, Inc. currently shows a below-average growth signal. The stock trades at a P/E of 160.7 with a market cap of $41,708. Investors should review the full earnings analysis for detailed insights.

Is Ventas, Inc. planning capital expenditure?

- Majority of investments in senior housing, particularly SHOP portfolio, with $6+ billion added in investments.

Keep Ventas, Inc. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.